1oga › Citations

A structural basis for immunodominant human T cell receptor recognition.

Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY
Nat Immunol 4 657-63 (2003)
Cited: 242 times
EuropePMC logo PMID: 12796775

Abstract

The anti-influenza CD8+ T cell response in HLA-A2-positive adults is almost exclusively directed at residues 58-66 of the virus matrix protein (MP(58-66)). V(beta)17V(alpha)10.2 T cell receptors (TCRs) containing a conserved arginine-serine-serine sequence in complementarity determining region 3 (CDR3) of the V(beta) segment dominate this response. To investigate the molecular basis of immunodominant selection in an outbred population, we have determined the crystal structure of V(beta)17V(alpha)10.2 in complex with MP(58-66)-HLA-A2 at a resolution of 1.4 A. We show that, whereas the TCR typically fits over an exposed side chain of the peptide, in this structure MP(58-66) exposes only main chain atoms. This distinctive orientation of V(beta)17V(alpha)10.2, which is almost orthogonal to the peptide-binding groove of HLA-A2, facilitates insertion of the conserved arginine in V(beta) CDR3 into a notch in the surface of MP(58-66)-HLA-A2. This previously unknown binding mode underlies the immunodominant T cell response.

Reviews - 1oga mentioned but not cited (8)

  1. The molecular basis of TCR germline bias for MHC is surprisingly simple. Garcia KC, Adams JJ, Feng D, Ely LK. Nat Immunol 10 143-147 (2009)
  2. Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Armstrong KM, Piepenbrink KH, Baker BM. Biochem J 415 183-196 (2008)
  3. TCR Recognition of Peptide-MHC-I: Rule Makers and Breakers. Szeto C, Lobos CA, Nguyen AT, Gras S. Int J Mol Sci 22 E68 (2020)
  4. Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities. Armstrong KM, Insaidoo FK, Baker BM. J Mol Recognit 21 275-287 (2008)
  5. Coevolution of T-cell receptors with MHC and non-MHC ligands. Castro CD, Luoma AM, Adams EJ. Immunol Rev 267 30-55 (2015)
  6. The versatility of the αβ T-cell antigen receptor. Bhati M, Cole DK, McCluskey J, Sewell AK, Rossjohn J. Protein Sci 23 260-272 (2014)
  7. The perception and response of T cells to a changing environment are based on the law of initial value. Huseby ES, Teixeiro E. Sci Signal 15 eabj9842 (2022)
  8. Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology. Reinherz EL, Hwang W, Lang MJ. Proc Natl Acad Sci U S A 120 e2215694120 (2023)

Articles - 1oga mentioned but not cited (51)



Reviews citing this publication (41)

  1. How TCRs bind MHCs, peptides, and coreceptors. Rudolph MG, Stanfield RL, Wilson IA. Annu Rev Immunol 24 419-466 (2006)
  2. T cell antigen receptor recognition of antigen-presenting molecules. Rossjohn J, Gras S, Miles JJ, Turner SJ, Godfrey DI, McCluskey J. Annu Rev Immunol 33 169-200 (2015)
  3. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Yewdell JW. Immunity 25 533-543 (2006)
  4. Structural determinants of T-cell receptor bias in immunity. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Nat Rev Immunol 6 883-894 (2006)
  5. Harnessing invariant NKT cells in vaccination strategies. Cerundolo V, Silk JD, Masri SH, Salio M. Nat Rev Immunol 9 28-38 (2009)
  6. The molecular basis for public T-cell responses? Venturi V, Price DA, Douek DC, Davenport MP. Nat Rev Immunol 8 231-238 (2008)
  7. Evolutionarily conserved amino acids that control TCR-MHC interaction. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW. Annu Rev Immunol 26 171-203 (2008)
  8. Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination. Miles JJ, Douek DC, Price DA. Immunol Cell Biol 89 375-387 (2011)
  9. How T cells 'see' antigen. Krogsgaard M, Davis MM. Nat Immunol 6 239-245 (2005)
  10. Understanding the drivers of MHC restriction of T cell receptors. La Gruta NL, Gras S, Daley SR, Thomas PG, Rossjohn J. Nat Rev Immunol 18 467-478 (2018)
  11. Immunoglobulin superfamily cell adhesion molecules: zippers and signals. Aricescu AR, Jones EY. Curr Opin Cell Biol 19 543-550 (2007)
  12. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Godfrey DI, Rossjohn J, McCluskey J. Immunity 28 304-314 (2008)
  13. A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, Rossjohn J. Immunol Rev 250 61-81 (2012)
  14. T-cell receptor bias and immunity. Gras S, Kjer-Nielsen L, Burrows SR, McCluskey J, Rossjohn J. Curr Opin Immunol 20 119-125 (2008)
  15. Immunity to seasonal and pandemic influenza A viruses. Valkenburg SA, Rutigliano JA, Ellebedy AH, Doherty PC, Thomas PG, Kedzierska K. Microbes Infect 13 489-501 (2011)
  16. Establishment and recall of CD8+ T-cell memory in a model of localized transient infection. Kedzierska K, La Gruta NL, Turner SJ, Doherty PC. Immunol Rev 211 133-145 (2006)
  17. Structural and functional aspects of lipid binding by CD1 molecules. Silk JD, Salio M, Brown J, Jones EY, Cerundolo V. Annu Rev Cell Dev Biol 24 369-395 (2008)
  18. Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. Deng L, Mariuzza RA. Trends Biochem Sci 32 500-508 (2007)
  19. Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity. Kedzierska K, La Gruta NL, Stambas J, Turner SJ, Doherty PC. Mol Immunol 45 607-618 (2008)
  20. Specificity on a knife-edge: the alphabeta T cell receptor. Clements CS, Dunstone MA, Macdonald WA, McCluskey J, Rossjohn J. Curr Opin Struct Biol 16 787-795 (2006)
  21. Unusual features of self-peptide/MHC binding by autoimmune T cell receptors. Nicholson MJ, Hahn M, Wucherpfennig KW. Immunity 23 351-360 (2005)
  22. Understanding the complexity and malleability of T-cell recognition. Miles JJ, McCluskey J, Rossjohn J, Gras S. Immunol Cell Biol 93 433-441 (2015)
  23. Understanding the structural dynamics of TCR-pMHC complex interactions. Kass I, Buckle AM, Borg NA. Trends Immunol 35 604-612 (2014)
  24. Characterization of CD8+ T cell repertoire diversity and persistence in the influenza A virus model of localized, transient infection. Turner SJ, Kedzierska K, La Gruta NL, Webby R, Doherty PC. Semin Immunol 16 179-184 (2004)
  25. TCR-MHC docking orientation: natural selection, or thymic selection? Collins EJ, Riddle DS. Immunol Res 41 267-294 (2008)
  26. T-large granular lymphocyte leukemia: current molecular concepts. Wlodarski MW, Schade AE, Maciejewski JP. Hematology 11 245-256 (2006)
  27. CD8 T cell responses to viral infections in sequence. Brehm MA, Selin LK, Welsh RM. Cell Microbiol 6 411-421 (2004)
  28. T cell allorecognition and MHC restriction--A case of Jekyll and Hyde? Archbold JK, Ely LK, Kjer-Nielsen L, Burrows SR, Rossjohn J, McCluskey J, Macdonald WA. Mol Immunol 45 583-598 (2008)
  29. Allopeptides and the alloimmune response. Bharat A, Mohanakumar T. Cell Immunol 248 31-43 (2007)
  30. T cell receptor specificity for major histocompatibility complex proteins. Marrack P, Rubtsova K, Scott-Browne J, Kappler JW. Curr Opin Immunol 20 203-207 (2008)
  31. Autoreactive T cells in human type 1 diabetes. Tree TI, Peakman M. Endocrinol Metab Clin North Am 33 113-33, ix-x (2004)
  32. αβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapy. Reinherz EL. Cancer Immunol Res 3 305-312 (2015)
  33. Molecular tracking of antigen-specific T-cell clones during immune responses. Rufer N. Curr Opin Immunol 17 441-447 (2005)
  34. Antigen-driven T-cell repertoire selection during adaptive immune responses. Baumgartner CK, Malherbe LP. Immunol Cell Biol 89 54-59 (2011)
  35. The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease. Kedzierska K, Koutsakos M. Viral Immunol 33 160-178 (2020)
  36. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine. Fox A, Quinn KM, Subbarao K. Drugs 78 1297-1308 (2018)
  37. Some lessons from the systematic production and structural analysis of soluble (alpha)(beta) T-cell receptors. van Boxel GI, Stewart-Jones G, Holmes S, Sainsbury S, Shepherd D, Gillespie GM, Harlos K, Stuart DI, Owens R, Jones EY. J Immunol Methods 350 14-21 (2009)
  38. How age and infection history shape the antigen-specific CD8+ T-cell repertoire: Implications for vaccination strategies in older adults. Lanfermeijer J, Borghans JAM, van Baarle D. Aging Cell 19 e13262 (2020)
  39. Forward Vaccinology: CTL Targeting Based upon Physical Detection of HLA-Bound Peptides. Reinherz EL, Keskin DB, Reinhold B. Front Immunol 5 418 (2014)
  40. Legacy of the influenza pandemic 1918: The host T cell response. McMichael AJ. Biomed J 41 242-248 (2018)
  41. Stereo electronic principles for selecting fully-protective, chemically-synthesised malaria vaccines. Patarroyo ME, Bermudez A, Alba MP, Patarroyo MA, Suarez C, Aza-Conde J, Moreno-Vranich A, Vanegas M. Front Immunol 13 926680 (2022)

Articles citing this publication (142)



Quick links